Chief Information Officer · Alignment Healthcare, Inc. · Common Stock
Open-market sale
$1.2M reported value · 11.5% of prior position
Disclosed 1 business day after execution (deadline: 2)
First recorded trade by this actor in this security
4 other actors traded the same direction within 14 days
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 27 | Kim HyongChief Medical Officer | Open-market sale | SELL | $270K 32.5K sh | Oct 7, 2026 traded Oct 6, 2026 | |
| 34 | Konowiecki Joseph SDirector, EVP, Corporate Affairs | Open-market sale | SELL | $202K 23.5K sh | Sep 18, 2026 traded Sep 17, 2026 | |
| 25 | Kao John EDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $4.89M 385.3K sh | Sep 11, 2026 traded Sep 11, 2026 | |
| 25 | Kao John EDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $2.24M 172.6K sh | Sep 11, 2026 traded Sep 10, 2026 | |
| 40 | Maroney Dawn ChristinePresident | Open-market sale | SELL | $1.56M 122.7K sh | Sep 11, 2026 traded Sep 11, 2026 | |
| 15 | Kao John EDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $4.14M 298.0K sh | Aug 10, 2026 traded Aug 10, 2026 | |
| 12 | Maroney Dawn ChristinePresident | Open-market sale · 10b5-1 plan | SELL | $626K 30.0K sh | Apr 15, 2026 traded Apr 15, 2026 | |
| 12 | Kao John EDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $295K 13.8K sh | Apr 13, 2026 traded Apr 10, 2026 | |
| 12 | Kao John EDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $1.71M 82.3K sh | Apr 13, 2026 traded Apr 13, 2026 | |
| 19 | Kao John EDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $4.16M 201.9K sh | Apr 13, 2026 traded Apr 10, 2026 | |
| 19 | Kao John EDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $59K 2,727 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 29 | Kao John EDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $3.74M 177.3K sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 49 | Maroney Dawn ChristinePresident | Open-market sale | SELL | $4.99M 266.6K sh | Dec 30, 2025 traded Dec 29, 2025 | |
| 42 | Maroney Dawn ChristinePresident | Open-market sale | SELL | $300K 15.5K sh | Dec 30, 2025 traded Dec 29, 2025 | |
| 42 | Joyce Christopher JChief Legal and Admin. Officer | Open-market sale | SELL | $286K 15.3K sh | Dec 30, 2025 traded Dec 29, 2025 | |
| 36 | Joyce Christopher JChief Legal and Admin. Officer | Open-market sale | SELL | $17K 888 sh | Dec 30, 2025 traded Dec 29, 2025 | |
| 36 | Kim HyongChief Medical Officer | Open-market sale | SELL | $13K 696 sh | Dec 30, 2025 traded Dec 29, 2025 | |
| 56 | Kao John EDirector, Chief Executive Officer | Open-market sale | SELL | $10.71M 572.4K sh | Dec 30, 2025 traded Dec 29, 2025 | |
| 42 | Kao John EDirector, Chief Executive Officer | Open-market sale | SELL | $644K 33.2K sh | Dec 30, 2025 traded Dec 29, 2025 | |
| 39 | Scavo Robert L.Chief Information Officer | Open-market sale | SELL | $74K 3,813 sh | Dec 30, 2025 traded Dec 29, 2025 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $1,229,482
Scavo Robert L. filed this Form 4 reporting a open-market sale of ALHC on Dec 29, 2025. It became public on Dec 30, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.